NCT07216703 · Interventional trial
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Overall registry status Recruiting
Phase 3
Conditions Cervical Cancer
Delaware Valley sites
- Asplundh Cancer Pavilion ( Site 5002) · Willow Grove, PA · Montgomery County · Recruiting
- Honickman Center ( Site 5033) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory